when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
drugs
Olanzapine

drug

olanzapine ODT

Marketedupdated 3mo ago

by Hisun Pharmaceutical USA Inc

Approved

community read0 votes

🐶 often sniffed alongside

top 8

tagApproval598 co-mentions · 299 sources
drugLYBALVI444 co-mentions · 300 sources
drugolanzapine ER437 co-mentions · 300 sources
drugOLANZAPINE437 co-mentions · 300 sources
tagSmall Molecule239 co-mentions · 239 sources
drugOLANZAPINE AND FLUOXETINE HYDROCHLORIDE180 co-mentions · 60 sources
drugProzac120 co-mentions · 60 sources
drugfluoxetine hydrochloride DR120 co-mentions · 60 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 27 investigational indications.

indications

investigational

Schizophrenia

all catalysts(79)

approval · 79

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

OLANZAPINE — FDA approval

view all 79 catalysts →

Trials studying olanzapine ODT

phase3Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medicationsrecruitingn=380
phase3Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorderrecruitingn=220
phase1Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disordercompletedn=106
phase1An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophreniacompletedn=153
—A Study of Olanzapine in Participants With Bipolar Disorder.recruitingn=3,000
phase1Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidonecompletedn=81
phase1Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophreniacompletedn=24
phase3A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniformcompletedn=337

more trials →

News(0)

no news has mentioned this drug yet

brand

Olanzapine

generic

olanzapine

MOA

12.1 Mechanism of Action The mechanism of action of olanzapine, in the listed indications is unclear. However, the efficacy of olanzapine in schizophrenia could be mediated through a combination of dopamine and serotonin type 2 (5HT2) antagonism.

indication

Bipolar Disorder (Manic Depression)

phase

marketed

Data sources

openFDA · ClinicalTrials.gov

last refreshed 23m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?